Intracellular delivery is a key step in biological research and has enabled decades of
biomedical discoveries. It is also becoming increasingly important in industrial and medical …

Natural cells have been explored as drug carriers for a long period. They have received
growing interest as a promising drug delivery system (DDS) until recently along with the …

Metal-free magnetic resonance imaging (MRI) agents could overcome the established
toxicity associated with metal-based agents in some patient populations and enable new …

Inspired by nature, innovative devices have been made to imitate the morphology and
functions of natural red blood cells (RBCs). Here, we report a red blood cell-mimetic …

Red blood cells (RBCs), the “innate carriers” in blood vessels, are gifted with many unique
advantages in drug transportation over synthetic drug delivery systems (DDSs). Herein, a …

Drug delivery using natural biological carriers, especially erythrocytes, is a rapidly
developing field. Such erythrocytes can act as carriers that prolong the drug's action due to …

Recent advances in magnetic resonance imaging (MRI) contrast agents have provided new
capabilities for biomarker detection through molecular imaging. MRI contrast agents based …

Molecular recognition involving glycoprotein-mediated interactions is ubiquitous in both
normal and pathological natural processes. Therefore, visualization of these interactions …

From the early days of CEST agents' disclosure, it was evident that their potential for in vivo
applications was strongly hampered by the intrinsic low sensitivity. Therefore, much work …

The rationale for the design of drug delivery nanoparticles is traditionally based on co-
solvent self-assembly following bottom-up approaches or in combination with top-down …